ANIXA BIOSCIENCES, INC. Entity Listing, Par Value Per Share
ANIXA BIOSCIENCES, INC. (ANIX) reported Entity Listing, Par Value Per Share of $0.01 per share for the 9-month period ending 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Notes › Cover Page
dei:EntityListingParValuePerShare · last filed 2026-09-09
- ANIXA BIOSCIENCES, INC. entity listing, par value per share for the quarter ending 2026-01-31 was $0.01, a 0.00% change year-over-year.
- ANIXA BIOSCIENCES, INC. entity listing, par value per share for the quarter ending 2025-01-31 was $0.01.
- ANIXA BIOSCIENCES, INC. entity listing, par value per share for fiscal 2025 was $0.01, a 0.00% change from fiscal 2024.
- ANIXA BIOSCIENCES, INC. entity listing, par value per share for fiscal 2024 was $0.01.
| Period end | Entity Listing, Par Value Per Share 3 month | Entity Listing, Par Value Per Share 6 month | Entity Listing, Par Value Per Share 9 month | Entity Listing, Par Value Per Share 12 month |
|---|---|---|---|---|
| 2026-07-31 | $0.01 10-Q · filed 2026-09-09 | |||
| 2026-04-30 | $0.01 10-Q · filed 2026-06-10 | |||
| 2026-01-31 | $0.01 10-Q · filed 2026-03-09 | |||
| 2025-10-31 | $0.01 10-K · filed 2026-01-12 | |||
| 2025-07-31 | $0.01 10-Q · filed 2025-09-10 | |||
| 2025-04-30 | $0.01 10-Q · filed 2025-05-28 | |||
| 2025-01-31 | $0.01 10-Q · filed 2025-03-11 | |||
| 2024-10-31 | $0.01 10-K · filed 2025-01-10 | |||
| 2024-07-31 | $0.01 10-Q · filed 2024-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |